Company Analysis

Kymera Therapeutics, Inc. (KYMR)

Nasdaq: KYMR · Biological Products, (No Diagnostic Substances) · Watertown, MA · filing with the SEC since 2020
Grade5.1
◀ Past 6.2● Present 5.3▶ Future 3.6
1 est.

Who runs Kymera Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Mainolfi Nello
Chief Executive Officer. First filing Aug 2020, latest Oct 1, 2026, 22 filings in all.
Officers reporting now
7
of 30 people with a filing in the last fifteen months
Directors reporting now
23
38 people on the record since 2020
Officerssales are open-market, Oct 1, 2025 to Oct 1, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mainolfi NelloChief Executive OfficerAug 2020Oct 1, 202626 · $36.8M
Adams BrianChief Legal OfficerSep 2025Sep 4, 20263 · $700,000
Rooney TerenceChief Medical OfficerJul 2026Jul 27, 2026none
Jacobs Bruce N.Chief Financial OfficerAug 2020Jul 2, 202615 · $10.0M
Goodman NoahChief Business OfficerApr 2025Jul 2, 20269 · $2.2M
Chadwick Jeremy GChief Operating OfficerMay 2023May 27, 202629 · $15.6M
Gollob JaredChief Medical OfficerAug 2020Mar 4, 202618 · $9.1M
Directorssales are open-market, Oct 1, 2025 to Oct 1, 2026
NameRoleFirst filingLatest filingSales, 12 months
Booth BrucedirectorAug 2020Jul 2, 2026160 · $226M
Biotechnology Value Fund II LPdirectorAug 2020Jun 26, 20264 · $174M
Biotechnology Value Fund L PdirectorAug 2020Jun 26, 2026none
Biotechnology Value Trading Fund Os LPdirectorAug 2020Jun 26, 2026none
Bvf Gp Holdings LLCdirectorAug 2020Jun 26, 2026none
Bvf I Gp LLCdirectorAug 2020Jun 26, 2026none
Bvf II Gp LLCdirectorAug 2020Jun 26, 2026none
Bvf Inc/ildirectorAug 2020Jun 26, 2026none
Bvf Partners L P/ildirectorAug 2020Jun 26, 2026none
Bvf Partners Os Ltd.directorAug 2020Jun 26, 2026none
Lampert Mark NdirectorAug 2020Jun 26, 2026none
667, L.P.directorApr 2024Jun 25, 2026none
Albers Jeffrey W.directorAug 2020Jun 25, 20263 · $700,000
Baker Bros. Advisors (Gp) LLCdirectorApr 2024Jun 25, 2026none
Baker Bros. Advisors LPdirectorApr 2024Jun 25, 2026none
Baker Brothers Life Sciences LPdirectorApr 2024Jun 25, 2026none
Baker FelixdirectorApr 2024Jun 25, 2026none
Baker JuliandirectorApr 2024Jun 25, 2026none
Esposito PameladirectorSep 2020Jun 25, 202612 · $3.1M
Hrustanovic GorjandirectorAug 2020Jun 25, 2026none
Maraganore JohndirectorJan 2022Jun 25, 2026none
Ridloff ElenadirectorMar 2021Jun 25, 20264 · $1.3M
Sandor VictordirectorNov 2022Jun 25, 2026none
Earlier names on the record18, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton KYMR · research, not advice